简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-11-03 08:53 GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies
2023-11-02 12:06 Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
2023-11-02 11:12 Start of Sales of Stainless Steel Materials for Injection Needles to Europe and China Compliant with the European Medical Device Regulations Cobalt Composition Regulations
2023-11-02 10:42 Genome Insight Secures $23 Million in Series B-2 Funding Round
2023-11-01 14:38 Corebridge Financial Completes Sale of Laya Healthcare to AXA
2023-10-31 10:52 ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
2023-10-30 16:13 Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
2023-10-30 08:58 United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
2023-10-27 16:23 GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
2023-10-27 16:21 Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
2023-10-27 10:01 Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
2023-10-26 12:56 Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
2023-10-26 09:20 EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
2023-10-24 11:20 Nagoya Anesthesia Clinic Initiates Inbound Medical Treatment for Treatment-Resistant Depression and Intractable Chronic Pain Using Ketamine
2023-10-24 11:02 Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
2023-10-23 08:57 Philip Morris International Submits Applications to Commercialize IQOS ILUMA Tobacco Heating System to U.S. Food and Drug Administration
2023-10-20 11:50 Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
2023-10-19 18:15 ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023
2023-10-19 11:21 European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
2023-10-19 10:26 Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

Business Wire Weibo

Press Releases

Latest Releases